These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
252 related items for PubMed ID: 21958210
1. Role of functional polymorphism of matrix metalloproteinase-2 (-1306 C/T and -168 G/T) and MMP-9 (-1562 C/T) promoter in oral submucous fibrosis and head and neck squamous cell carcinoma in an Indian population. Chaudhary AK, Pandya S, Mehrotra R, Singh M, Singh M. Biomarkers; 2011 Nov; 16(7):577-86. PubMed ID: 21958210 [Abstract] [Full Text] [Related]
2. Functional polymorphism of the MMP-1 promoter (-1607 1G/2G) in potentially malignant and malignant head and neck lesions in an Indian population. Chaudhary AK, Pandya S, Mehrotra R, Bharti AC, Jain S, Singh M. Biomarkers; 2010 Dec; 15(8):684-92. PubMed ID: 20860530 [Abstract] [Full Text] [Related]
6. No association between the C-1562T polymorphism in the promoter of matrix metalloproteinase-9 gene and non-small cell lung carcinoma. Wang Y, Fang S, Wei L, Wang R, Jin X, Wen D, Li Y, Guo W, Wang N, Zhang J. Lung Cancer; 2005 Aug; 49(2):155-61. PubMed ID: 15949868 [Abstract] [Full Text] [Related]
7. Functional genotype in matrix metalloproteinases-2 promoter is a risk factor for oral carcinogenesis. Lin SC, Lo SS, Liu CJ, Chung MY, Huang JW, Chang KW. J Oral Pathol Med; 2004 Aug; 33(7):405-9. PubMed ID: 15250832 [Abstract] [Full Text] [Related]
10. [Correlations of polymorphisms in matrix metalloproteinase-3 and -7 promoters to susceptibility to brain astrocytoma]. Lu ZQ, Wang YM, Cao YY, Zhang QJ, Zhang XH, Li YH, Wang HS, Xie HL, Jiao BH, Zhang JH. Ai Zheng; 2007 May; 26(5):463-8. PubMed ID: 17672933 [Abstract] [Full Text] [Related]
12. [Association of functional polymorphisms in matrix metalloproteinase-2 (MMP-2) and MMP-9 genes with risk of gastric cancer in a Chinese population]. Zhang XM, Miao XP, Xiong P, Yu CY, Tan W, Qu SN, Sun T, Zhou YF, Lin DX. Ai Zheng; 2004 Nov; 23(11):1233-7. PubMed ID: 15522165 [Abstract] [Full Text] [Related]
14. Correlation between functional genotypes in the matrix metalloproteinases-1 promoter and risk of oral squamous cell carcinomas. Lin SC, Chung MY, Huang JW, Shieh TM, Liu CJ, Chang KW. J Oral Pathol Med; 2004 Jul; 33(6):323-6. PubMed ID: 15200479 [Abstract] [Full Text] [Related]
15. Association of matrix metalloproteinase (MMP)-1 promoter polymorphism with head and neck squamous cell carcinoma. Hashimoto T, Uchida K, Okayama N, Imate Y, Suehiro Y, Hamanaka Y, Ueyama Y, Shinozaki F, Yamashita H, Hinoda Y. Cancer Lett; 2004 Jul 28; 211(1):19-24. PubMed ID: 15194213 [Abstract] [Full Text] [Related]
16. Gene polymorphisms of matrix metalloproteinase-2, -9 and -12 in periodontal health and severe chronic periodontitis. Gürkan A, Emingil G, Saygan BH, Atilla G, Cinarcik S, Köse T, Berdeli A. Arch Oral Biol; 2008 Apr 28; 53(4):337-45. PubMed ID: 18155181 [Abstract] [Full Text] [Related]
17. The role of genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes in head and neck cancer. O-Charoenrat P, Khantapura P. Oral Oncol; 2006 Mar 28; 42(3):257-67. PubMed ID: 16275157 [Abstract] [Full Text] [Related]
20. Functional haplotypes in the promoter of matrix metalloproteinase-2 predict risk of the occurrence and metastasis of esophageal cancer. Yu C, Zhou Y, Miao X, Xiong P, Tan W, Lin D. Cancer Res; 2004 Oct 15; 64(20):7622-8. PubMed ID: 15492291 [Abstract] [Full Text] [Related] Page: [Next] [New Search]